Efficacy and Safety of Epi-On vs Epi-Off Corneal Cross-Linking in Corneal Ectasia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Reem O Nughays,1 Abdullah S Bazayd,1 Lujain A Alshamekh,2 Reemas A Alshammari,3 Mohammed A Alenezi,4 Hashem Y Dahlan,5 Jana A Alsubhi,6 Sara G Alshammri,7 Nouf A AlQurashi,8 Abdulaziz H Aldajani,9 Abdulrahman H Alrammah,9 Mariam N Alenezi,10 Areej Abdullah Almutairi,11 Abdulaziz F Alomayri,12 Saeed Alghamdi13 1College of Medicine, King Saud bin Abdulaziz for Health Sciences, Jeddah, Saudi Arabia; 2College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia; 3College of Medicine, Imam Mohammed bin Saud Islamic University, Riyadh, Saudi Arabia; 4College of Medicine, Northern Border University, Arar, Saudi Arabia; 5College of Medicine, Umm-Al Qura University, Makkah, Saudi Arabia; 6College of Medicine, University of Jeddah, Jeddah, Saudi Arabia; 7College of Medicine, Vision College, Riyadh, Saudi Arabia; 8College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; 9College of Medicine, King Faisal University, Al-Hasa, Saudi Arabia; 10General Surgery Department, Farwaniya Hospital, Farwaniya, Kuwait; 11College of Medicine, Taif University, Taif, Saudi Arabia; 12College of Medicine, King Saud University, Riyadh, Saudi Arabia; 13Ophthalmology Department, King Abdulaziz Medical City, Jeddah, Saudi ArabiaCorrespondence: Reem O Nughays, College of Medicine, King Saud bin Abdulaziz for Health Sciences, Jeddah, Saudi Arabia, Tel +966543200330, Email [email protected] Saeed Alghamdi, Ophthalmology Department, King Abdulaziz Medical City, Jeddah, Saudi Arabia, Email [email protected]: Corneal ectasias are progressive conditions that impair vision and quality of life. Corneal collagen cross-linking (CXL) aims to halt disease progression by strengthening the cornea. This review compares two CXL methods, epithelium-on (epi-on) and epithelium-off (epi-off), to assess their safety and effectiveness for managing corneal ectasia. A systematic search up to July 2024 of PubMed, Medline, Web of Science, Cochrane Central, Google Scholar, and Scopus identified 13 randomized controlled trials (RCTs) involving 872 patients and 1041 eyes. Data were analyzed following PRISMA guidelines using fixed-effects and random-effects models. The primary outcome was the change in maximal keratometry (Kmax) at 12 months, with secondary outcomes including safety profile, best-corrected visual acuity (BCVA), uncorrected visual acuity (UCVA), spherical equivalent (SE), and endothelial cell count (ECC). The findings revealed no statistically significant differences between epithelium-on (epi-on) and epithelium-off (epi-off) CXL in Kmax, BCVA, UCVA, SE, or corneal curvature parameters. However, epithelium-off (epi-off) CXL was associated with less endothelial cell loss and higher rates of side effects, including corneal haze and postoperative discomfort. The choice of treatment should be tailored to individual patient needs, balancing clinical goals and safety considerations. This review highlights the need for further studies to optimize CXL approaches and improve outcomes while minimizing complications.Keywords: corneal ectasia, corneal collagen cross-linking (CXL), epi-on, epi-off, keratoconus, maximal keratometry (Kmax), visual acuity, endothelial cell count (ECC)

Institutions

Publication Details

Journal
SHILAP Revista de lepidopterología
Published
2025-05-01
Primary Topic
Corneal surgery and disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and Safety of Epi-On vs Epi-Off Corneal Cross-Linking in Corneal Ectasia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

SHILAP Revista de lepidopterología
Corneal surgery and disorders
article

Efficacy and Safety of Epi-On vs Epi-Off Corneal Cross-Linking in Corneal Ectasia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

article en

Abstract

Reem O Nughays,1 Abdullah S Bazayd,1 Lujain A Alshamekh,2 Reemas A Alshammari,3 Mohammed A Alenezi,4 Hashem Y Dahlan,5 Jana A Alsubhi,6 Sara G Alshammri,7 Nouf A AlQurashi,8 Abdulaziz H Aldajani,9 Abdulrahman H Alrammah,9 Mariam N Alenezi,10 Areej Abdullah Almutairi,11 Abdulaziz F Alomayri,12 Saeed Alghamdi13 1College of Medicine, King Saud bin Abdulaziz for Health Sciences, Jeddah, Saudi Arabia; 2College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia; 3College of Medicine, Imam Mohammed bin Saud Islamic University, Riyadh, Saudi Arabia; 4College of Medicine, Northern Border University, Arar, Saudi Arabia; 5College of Medicine, Umm-Al Qura University, Makkah, Saudi Arabia; 6College of Medicine, University of Jeddah, Jeddah, Saudi Arabia; 7College of Medicine, Vision College, Riyadh, Saudi Arabia; 8College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; 9College of Medicine, King Faisal University, Al-Hasa, Saudi Arabia; 10General Surgery Department, Farwaniya Hospital, Farwaniya, Kuwait; 11College of Medicine, Taif University, Taif, Saudi Arabia; 12College of Medicine, King Saud University, Riyadh, Saudi Arabia; 13Ophthalmology Department, King Abdulaziz Medical City, Jeddah, Saudi ArabiaCorrespondence: Reem O Nughays, College of Medicine, King Saud bin Abdulaziz for Health Sciences, Jeddah, Saudi Arabia, Tel +966543200330, Email [email protected] Saeed Alghamdi, Ophthalmology Department, King Abdulaziz Medical City, Jeddah, Saudi Arabia, Email [email protected]: Corneal ectasias are progressive conditions that impair vision and quality of life. Corneal collagen cross-linking (CXL) aims to halt disease progression by strengthening the cornea. This review compares two CXL methods, epithelium-on (epi-on) and epithelium-off (epi-off), to assess their safety and effectiveness for managing corneal ectasia. A systematic search up to July 2024 of PubMed, Medline, Web of Science, Cochrane Central, Google Scholar, and Scopus identified 13 randomized controlled trials (RCTs) involving 872 patients and 1041 eyes. Data were analyzed following PRISMA guidelines using fixed-effects and random-effects models. The primary outcome was the change in maximal keratometry (Kmax) at 12 months, with secondary outcomes including safety profile, best-corrected visual acuity (BCVA), uncorrected visual acuity (UCVA), spherical equivalent (SE), and endothelial cell count (ECC). The findings revealed no statistically significant differences between epithelium-on (epi-on) and epithelium-off (epi-off) CXL in Kmax, BCVA, UCVA, SE, or corneal curvature parameters. However, epithelium-off (epi-off) CXL was associated with less endothelial cell loss and higher rates of side effects, including corneal haze and postoperative discomfort. The choice of treatment should be tailored to individual patient needs, balancing clinical goals and safety considerations. This review highlights the need for further studies to optimize CXL approaches and improve outcomes while minimizing complications.Keywords: corneal ectasia, corneal collagen cross-linking (CXL), epi-on, epi-off, keratoconus, maximal keratometry (Kmax), visual acuity, endothelial cell count (ECC)

SHILAP Revista de lepidopterología
Faculty (United Kingdom) (GB), Medication Management (United States) (US), Ophthalmology Associates (United States) (US), College of the Mainland (US)
Openalex Percentile: Top 37%
Corneal surgery and disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.